Information om | Engelska ordet GVHD
GVHD
Antal bokstäver
4
Är palindrom
Nej
Sök efter GVHD på:
Wikipedia
(Svenska) Wiktionary
(Svenska) Wikipedia
(Engelska) Wiktionary
(Engelska) Google Answers
(Engelska) Britannica
(Engelska)
(Svenska) Wiktionary
(Svenska) Wikipedia
(Engelska) Wiktionary
(Engelska) Google Answers
(Engelska) Britannica
(Engelska)
Exempel på hur man kan använda GVHD i en mening
- Other causes of ductopenia include failing liver transplant, Hodgkin's lymphoma, graft-versus-host disease (GVHD), sarcoid, cytomegalovirus infection, HIV, and medication toxicity, such as phenothiazines.
- Transfer of immune cells is made between different individuals of monozygotic twins in human or of the same pure line in experimental animals from immunologically sensitized to naive host, where transferred cells are engrafted without rejection or GVHD in the new host.
- Second, a thymus transplantation can cause a non-donor T cell-related GVHD because the recipients thymocytes would use the donor thymus cells as models when going through the negative selection to recognize self-antigens, and could therefore still mistake own structures in the rest of the body for being non-self.
- He is best known for his research on chronic GVHD, the most common late effect in cancer survivors who underwent allogeneic stem cell transplantations as a form of treatment.
- Practices of microtransplantation has shown none graft-versus-host disease (GVHD) till present, thus immunosuppressive drugs for relieving GVHD wouldn't be necessary.
- Additionally, GM-CSF has been shown to be instrumental in donor T-cell licensing of host and donor-derived myeloid cells in graft versus host disease (GVHD) following hematopoietic allotransplantation.
- Besides, it has been shown that the adoptive transfer of alloreactive NK cells does not cause graft-versus-host disease (GVHD), but instead suppresses GVHD.
- Belumosudil is indicated for the treatment of people aged twelve years and older with chronic graft-versus-host disease (chronic GVHD) after failure of at least two prior lines of systemic therapy.
- Initially, Slavin pioneered the use of monoclonal antibodies anti-CD52 (Alemtuzumab, now approved by FDA as Lemtrada) for prevention of graft-vs-host disease (GVHD), the most serious complication of allogeneic stem cell transplantation, and later on for treatment of CLL and multiple sclerosis.
Förberedelsen av sidan tog: 749,01 ms.